BlossomHill Therapeutics, Inc.
BLSM
IPO
$22.00
-$0.93-4.06%
NASDAQ
IPO Factors
Debt Ratio
Growth Ratio
Industry
Institutional Support
Investment
IPO Size
Management
Market Reaction
Profitability
Revenue
Revenue Growth
Syndicate Size
Valuation
Headlines
9/9/2026
-
MarketBeat
9/4/2026
-
MarketBeat
9/4/2026
-
The Cerbat Gem
9/4/2026
-
MarketBeat
9/4/2026
-
The Cerbat Gem
9/3/2026
-
MarketBeat
9/3/2026
-
MarketBeat
9/3/2026
-
Globe Newswire
9/2/2026
-
The Cerbat Gem
9/2/2026
-
MarketBeat
9/2/2026
-
MarketBeat
9/2/2026
-
MarketBeat
9/1/2026
-
MarketBeat
9/1/2026
-
MarketBeat
9/1/2026
-
MarketBeat
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
Globe Newswire
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
TipRanks: TheFly
9/1/2026
-
TipRanks: TheFly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, August 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 2 and 6 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(858) 732-3880
Address
10255 Science Center Drive
Suite 200
San Diego, CA 92121
Suite 200
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an...
more